Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-05-09 00:00:00 ET · period of report 2022-05-05 · accession 0001765581-22-000043 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-09 | 2022-05-05 | JAZZ | Tovey Christopher J. | EVP, COO, Managing Dir E | F - Tax | $153.22 | -1,096 | 15.8K | -6% | -$167.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-05-05 | F | D | 1,096 | $153.22 | 15,840 | D | — | — |